The diversity of direct effects of IL-1 on tumor cells may be related to the differentiation status of cells and also to the type of assay, most of which do not discriminate between proliferation as self renewal or as transition to the terminal stage of differentiation, as described for IL-1 function on glioblastomas [51]. This evidence concerns the gene IL1B and neoplasm.